Calcineurin-AKAP interactions: therapeutic targeting of a pleiotropic enzyme with a little help from its friends

J Physiol. 2020 Jul;598(14):3029-3042. doi: 10.1113/JP276756. Epub 2018 Dec 26.

Abstract

The ubiquitous Ca2+ /calmodulin-dependent phosphatase calcineurin is a key regulator of pathological cardiac hypertrophy whose therapeutic targeting in heart disease has been elusive due to its role in other essential biological processes. Calcineurin is targeted to diverse intracellular compartments by association with scaffold proteins, including by multivalent A-kinase anchoring proteins (AKAPs) that bind protein kinase A and other important signalling enzymes determining cardiac myocyte function and phenotype. Calcineurin anchoring by AKAPs confers specificity to calcineurin function in the cardiac myocyte. Targeting of calcineurin 'signalosomes' may provide a rationale for inhibiting the phosphatase in disease.

Keywords: AKAP; calcineurin; heart; hypertrophy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • A Kinase Anchor Proteins* / metabolism
  • Calcineurin* / metabolism
  • Cardiomegaly / drug therapy
  • Friends
  • Humans
  • Signal Transduction

Substances

  • A Kinase Anchor Proteins
  • Calcineurin